Consumer Food · Founded 1944 · www.sukhjitgroup.com · BSE 524542 · NSE SUKJIT STRCH · ISIN INE450E01029
No Notes Added Yet
Business
Sukhjit Starch & Chemicals Ltd. is one of India's leading manufacturers of maize starch and its derivatives. The company processes maize (corn) to produce a wide range of products including maize starch, liquid glucose, dextrose monohydrate, modified starches, sorbitol, maltodextrin, and other co-products like corn germ, corn gluten, and fiber. These products serve diverse industries such as Food & Beverages, Pharmaceuticals, Textiles, Paper, Adhesives, and Animal Feed. The company's core business model involves procuring maize, transforming it into value-added starch and starch-derived products, and selling these to industrial customers, thereby making money from the sales of these processed goods.
Revenue Mix
The company primarily operates in the processing of maize to produce various components. While specific percentage breakdowns are not always uniformly published, the major product categories contributing to revenue include:
Starch & Derivatives: This is the largest segment, encompassing various forms of maize starch, liquid glucose, dextrose, modified starches, and maltodextrin.
Sorbitol: A key specialty product derived from starch, used in food, pharmaceutical, and cosmetic industries.
Co-products: Sales of corn germ, corn gluten, and fiber, which are by-products utilized in animal feed, oil extraction, and other industrial applications.
Industry
Sukhjit Starch & Chemicals operates in the Indian starch and derivatives industry, a mature but growing sector driven by demand from downstream industries. The industry is characterized by the presence of a few large national players and several regional manufacturers. Sukhjit Starch is an established and prominent player with a long operational history (since 1943) and multiple manufacturing facilities. It commands a significant position within the Indian market, catering to a broad customer base with a diversified product portfolio, positioning itself as a reliable supplier of essential industrial ingredients.
MOAT
Scale and Experience: With decades of operational experience and multiple large-scale manufacturing units, the company benefits from economies of scale in production, procurement, and distribution.
Diversified Product Portfolio: A wide range of starch and derivative products reduces reliance on any single product or end-user industry, offering resilience.
Established Customer Relationships: Long-standing relationships with a diverse set of industrial clients across various sectors.
Technical Expertise: Capability to produce specialized and high-quality derivatives, including pharmaceutical-grade products and Sorbitol, requiring specific technical know-how.
Growth Drivers
Increasing Demand from End-User Industries: Growth in India's processed food, pharmaceutical, textile, paper, and other industrial sectors directly translates to higher demand for starch and its derivatives.
Diversification into Value-Added Products: Focus on higher-margin specialty starches, modified starches, and other derivatives can improve profitability and revenue mix.
Capacity Expansion: Strategic investments in increasing manufacturing capacity to meet rising domestic and international demand.
Export Opportunities: Tapping into international markets for specialty starch products.
Bio-economy Trends: Growing preference for natural, renewable, and biodegradable ingredients can boost demand for starch-based solutions in various industrial applications.
Risks
Raw Material Price Volatility: Maize is the primary raw material, and its prices are subject to agricultural yields, weather patterns, government policies, and global commodity markets. Significant fluctuations can impact profitability.
Intense Competition: The Indian starch and derivatives market is competitive, which can lead to pricing pressures and margin erosion.
Regulatory Changes: Changes in food safety standards, environmental regulations, or agricultural policies could increase compliance costs and impact operations.
Economic Slowdown: A downturn in key end-user industries (e.g., food processing, textiles) could reduce demand for the company's products.
Environmental Concerns: Manufacturing processes are water and energy-intensive, posing risks related to resource availability and increasing environmental compliance costs.
Management & Ownership
Sukhjit Starch & Chemicals is a promoter-driven company, led by the founding family (K.S. Sarao group) and experienced professionals. The promoter group holds a significant majority stake, which is common among established Indian businesses. Key management personnel have long tenures, indicating stability and deep industry knowledge. The management's focus has historically been on operational efficiency, product quality, and strategic expansions.
Outlook
Sukhjit Starch & Chemicals is a well-established and important player within the Indian starch and derivatives industry, positioned to benefit from the sustained growth of its diverse end-user sectors. Its extensive experience, broad product portfolio, and established customer relationships provide a stable foundation. However, the company's profitability remains sensitive to the volatility of maize prices and competitive pressures within the industry. Future performance will largely depend on its ability to effectively manage raw material costs, continue strategic capacity expansions, and successfully expand into higher-value specialty segments to enhance margins and market share.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 370 | 395 | 368 | 375 | 360 | 369 | 315 | 347 | 402 | 396 |
| Other Income | 3 | 1 | 3 | 2 | 3 | 3 | 5 | 2 | 9 | 1 |
| Total Income | 373 | 396 | 370 | 377 | 363 | 372 | 319 | 349 | 411 | 397 |
| Total Expenditure | 337 | 361 | 336 | 346 | 343 | 350 | 296 | 327 | 376 | 366 |
| Operating Profit | 36 | 35 | 34 | 31 | 20 | 22 | 23 | 21 | 35 | 31 |
| Interest | 8 | 7 | 9 | 8 | 6 | 7 | 9 | 8 | 7 | 7 |
| Depreciation | 9 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 7 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 19 | 18 | 17 | 14 | 4 | 6 | 5 | 4 | 20 | 16 |
| Provision for Tax | 7 | 5 | 4 | 4 | 2 | 1 | 1 | 1 | 6 | 4 |
| Profit After Tax | 12 | 14 | 13 | 11 | 3 | 5 | 4 | 3 | 15 | 12 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 12 | 14 | 13 | 11 | 3 | 5 | 4 | 3 | 15 | 12 |
| Adjusted Earnings Per Share | 3.8 | 4.4 | 4 | 3.5 | 0.9 | 1.6 | 1.4 | 1 | 4.7 | 3.9 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 566 | 652 | 701 | 742 | 799 | 699 | 1159 | 1447 | 1375 | 1498 | 1432 | 1460 |
| Other Income | 3 | 2 | 5 | 3 | 10 | 8 | 3 | 3 | 10 | 8 | 19 | 17 |
| Total Income | 569 | 654 | 707 | 745 | 810 | 707 | 1162 | 1450 | 1385 | 1506 | 1451 | 1476 |
| Total Expenditure | 506 | 602 | 638 | 650 | 743 | 634 | 1001 | 1299 | 1247 | 1386 | 1350 | 1365 |
| Operating Profit | 62 | 52 | 68 | 95 | 66 | 73 | 161 | 150 | 138 | 120 | 101 | 110 |
| Interest | 15 | 13 | 18 | 16 | 19 | 23 | 24 | 28 | 33 | 30 | 31 | 31 |
| Depreciation | 12 | 12 | 15 | 13 | 14 | 22 | 35 | 36 | 35 | 36 | 34 | 34 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 35 | 27 | 36 | 66 | 33 | 28 | 102 | 86 | 70 | 54 | 36 | 45 |
| Provision for Tax | 13 | 9 | 13 | 24 | -0 | 7 | 29 | 23 | 20 | 14 | 9 | 12 |
| Profit After Tax | 22 | 18 | 23 | 42 | 33 | 21 | 73 | 63 | 50 | 40 | 27 | 34 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 22 | 18 | 23 | 42 | 33 | 21 | 73 | 63 | 50 | 40 | 27 | 34 |
| Adjusted Earnings Per Share | 7.6 | 6.2 | 7.7 | 14.1 | 11.2 | 7.1 | 23.3 | 20.3 | 16 | 12.8 | 8.6 | 11 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -0% | 15% | 10% |
| Operating Profit CAGR | -16% | -12% | 7% | 5% |
| PAT CAGR | -33% | -25% | 5% | 2% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -14% | -12% | 0% | 5% |
| ROE Average | 5% | 8% | 11% | 11% |
| ROCE Average | 8% | 10% | 13% | 13% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 215 | 237 | 253 | 283 | 315 | 333 | 413 | 466 | 503 | 543 | 567 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 56 | 47 | 53 | 148 | 194 | 187 | 134 | 111 | 86 | 82 | 87 |
| Other Non-Current Liabilities | 23 | 40 | 61 | 79 | 93 | 105 | 87 | 91 | 100 | 105 | 102 |
| Total Current Liabilities | 129 | 113 | 172 | 125 | 242 | 216 | 264 | 354 | 385 | 363 | 401 |
| Total Liabilities | 423 | 436 | 539 | 635 | 843 | 841 | 897 | 1021 | 1074 | 1094 | 1157 |
| Fixed Assets | 222 | 228 | 211 | 239 | 245 | 505 | 493 | 537 | 530 | 546 | 526 |
| Other Non-Current Assets | 17 | 22 | 57 | 136 | 289 | 82 | 88 | 41 | 56 | 43 | 33 |
| Total Current Assets | 184 | 187 | 271 | 259 | 309 | 255 | 316 | 443 | 488 | 505 | 598 |
| Total Assets | 423 | 436 | 539 | 635 | 843 | 841 | 897 | 1021 | 1074 | 1094 | 1157 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 21 | 18 | 7 | 18 | 16 | 14 | 12 | 12 | 13 | 16 | 16 |
| Cash Flow from Operating Activities | 86 | 40 | 11 | 126 | -61 | 116 | 144 | 41 | 78 | 68 | 4 |
| Cash Flow from Investing Activities | -30 | -29 | -43 | -146 | -92 | -68 | -85 | -43 | -39 | -1 | -10 |
| Cash Flow from Financing Activities | -59 | -21 | 42 | 18 | 151 | -50 | -60 | 2 | -36 | -66 | 6 |
| Net Cash Inflow / Outflow | -3 | -10 | 11 | -2 | -2 | -2 | -0 | 0 | 3 | 0 | -0 |
| Closing Cash & Cash Equivalent | 18 | 7 | 18 | 16 | 14 | 12 | 12 | 13 | 16 | 16 | 16 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 7.61 | 6.22 | 7.68 | 14.1 | 11.22 | 7.08 | 23.31 | 20.28 | 15.99 | 12.79 | 8.65 |
| CEPS(Rs) | 11.75 | 10.25 | 12.67 | 18.46 | 16.11 | 14.53 | 34.53 | 31.68 | 27.14 | 24.28 | 19.66 |
| DPS(Rs) | 1.25 | 1.25 | 1.63 | 3.75 | 1 | 1.5 | 5 | 4 | 4 | 1 | 1 |
| Book NAV/Share(Rs) | 72.85 | 80.15 | 85.8 | 95.97 | 106.57 | 112.7 | 132.05 | 149 | 160.88 | 173.82 | 181.59 |
| Core EBITDA Margin(%) | 10.06 | 7.3 | 8.84 | 12.4 | 6.99 | 9.22 | 13.61 | 10.17 | 9.31 | 7.46 | 5.77 |
| EBIT Margin(%) | 8.43 | 5.89 | 7.53 | 11.11 | 6.48 | 7.26 | 10.85 | 7.92 | 7.48 | 5.61 | 4.67 |
| Pre Tax Margin(%) | 5.87 | 4.02 | 5.05 | 8.91 | 4.09 | 4.03 | 8.8 | 5.96 | 5.08 | 3.6 | 2.48 |
| PAT Margin (%) | 3.77 | 2.69 | 3.2 | 5.61 | 4.15 | 2.99 | 6.29 | 4.38 | 3.63 | 2.67 | 1.89 |
| Cash Profit Margin (%) | 5.82 | 4.43 | 5.28 | 7.35 | 5.95 | 6.14 | 9.31 | 6.84 | 6.17 | 5.06 | 4.29 |
| ROA(%) | 5.29 | 4.27 | 4.65 | 7.09 | 4.48 | 2.48 | 8.38 | 6.61 | 4.77 | 3.69 | 2.4 |
| ROE(%) | 10.92 | 8.13 | 9.25 | 15.51 | 11.08 | 6.46 | 19.55 | 14.43 | 10.32 | 7.64 | 4.87 |
| ROCE(%) | 14.24 | 11.72 | 14.2 | 18.76 | 9.21 | 7.88 | 19.01 | 15.54 | 12.76 | 10.16 | 7.75 |
| Receivable days | 35.44 | 32.02 | 34.1 | 32.72 | 26.74 | 30.93 | 20.53 | 18.68 | 21.24 | 23.5 | 26.49 |
| Inventory Days | 42.09 | 29.9 | 37.89 | 35.97 | 47.03 | 66.29 | 33.05 | 36.24 | 54.33 | 55.73 | 67.37 |
| Payable days | 30.01 | 26.78 | 28.07 | 28.78 | 24.75 | 37.22 | 25.53 | 21.41 | 26.68 | 26.16 | 27.44 |
| PER(x) | 7.76 | 12.02 | 15.3 | 9.09 | 5.94 | 14.2 | 11.35 | 9.26 | 14.36 | 15.27 | 17.92 |
| Price/Book(x) | 0.81 | 0.93 | 1.37 | 1.34 | 0.63 | 0.89 | 2 | 1.26 | 1.43 | 1.12 | 0.85 |
| Dividend Yield(%) | 2.12 | 1.67 | 1.38 | 2.93 | 1.5 | 1.49 | 1.89 | 2.13 | 1.74 | 0.51 | 0.65 |
| EV/Net Sales(x) | 0.5 | 0.49 | 0.69 | 0.74 | 0.65 | 0.84 | 0.94 | 0.62 | 0.75 | 0.59 | 0.56 |
| EV/Core EBITDA(x) | 4.57 | 6.13 | 7.11 | 5.76 | 7.9 | 8.06 | 6.79 | 5.95 | 7.45 | 7.32 | 7.89 |
| Net Sales Growth(%) | 6.24 | 15.14 | 7.51 | 5.77 | 7.77 | -12.56 | 65.86 | 24.81 | -4.92 | 8.91 | -4.37 |
| EBIT Growth(%) | -3.32 | -19.89 | 32.59 | 54.35 | -37.14 | -2 | 147.84 | -8.97 | -10.15 | -18.32 | -20.47 |
| PAT Growth(%) | -1.97 | -18.28 | 23.47 | 83.56 | -20.36 | -36.91 | 248.47 | -13.02 | -21.15 | -20.02 | -32.35 |
| EPS Growth(%) | -1.95 | -18.29 | 23.47 | 83.56 | -20.37 | -36.89 | 229.18 | -13.02 | -21.15 | -20.04 | -32.37 |
| Debt/Equity(x) | 0.6 | 0.45 | 0.61 | 0.66 | 1.08 | 0.91 | 0.67 | 0.69 | 0.65 | 0.52 | 0.58 |
| Current Ratio(x) | 1.43 | 1.66 | 1.58 | 2.07 | 1.28 | 1.18 | 1.2 | 1.25 | 1.27 | 1.39 | 1.49 |
| Quick Ratio(x) | 0.98 | 1.17 | 1.04 | 1.64 | 0.65 | 0.71 | 0.79 | 0.75 | 0.67 | 0.77 | 0.74 |
| Interest Cover(x) | 3.3 | 3.15 | 3.04 | 5.05 | 2.71 | 2.25 | 5.28 | 4.05 | 3.12 | 2.79 | 2.14 |
| Total Debt/Mcap(x) | 0.74 | 0.48 | 0.45 | 0.49 | 1.73 | 1.02 | 0.33 | 0.54 | 0.45 | 0.47 | 0.68 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.33 | 66.33 | 66.01 | 66.04 | 66.04 | 66.04 | 66.07 | 66.07 | 66.15 | 66.15 |
| FII | 0.07 | 0.06 | 0.01 | 0 | 0.01 | 0 | 0.02 | 0 | 0 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 33.6 | 33.62 | 33.98 | 33.95 | 33.95 | 33.95 | 33.91 | 33.92 | 33.85 | 33.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.04 | 1.04 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.07 | 2.07 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.52 | 0.53 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.56 | 1.56 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | 0% | +15% | +10% |
| Operating Profit CAGR | -16% | -12% | +7% | +5% |
| PAT CAGR | -33% | -25% | +5% | +2% |
| Share Price CAGR | -14% | -12% | 0% | +5% |
| ROE Average | +5% | +8% | +11% | +11% |
| ROCE Average | +8% | +10% | +13% | +13% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.33 | 66.33 | 66.01 | 66.04 | 66.04 | 66.04 | 66.07 | 66.07 | 66.15 | 66.15 |
| FII | 0.07 | 0.06 | 0.01 | 0 | 0.01 | 0 | 0.02 | 0 | 0 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 33.6 | 33.62 | 33.98 | 33.95 | 33.95 | 33.95 | 33.91 | 33.92 | 33.85 | 33.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.04 | 1.04 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.06 | 2.07 | 2.07 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.52 | 0.53 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.56 | 1.56 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.